A Prospective Study of Stereotactic Body Radiotherapy in Oligometastatic Renal Cell Carcinoma

被引：0
|
作者：
Katipally, R. R. [1 ]
Rajeev-Kumar, G. [1 ]
Solanki, A. A. [2 ]
Arif, F. [1 ]
Eggener, S. E. [3 ]
Szmulewitz, R. Z. [4 ]
Stadler, W. M. [4 ]
Sweis, R. F. [4 ]
Pitroda, S. P. [1 ]
Liauw, S. [1 ]
机构：
[1] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL USA
[2] Loyola Univ Med Ctr, Dept Radiat Oncol, Maywood, IL USA
[3] Univ Chicago, Urol Sect, Dept Surg, Chicago, IL USA
[4] Univ Chicago, Sect Hematol Oncol, Dept Med, Chicago, IL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3203
引用
收藏
页码：E545 / E545
页数：1
相关论文
共 50 条
  • [21] Stereotactic Body Radiotherapy (SBRT) for the Treatment of oligometastatic Prostate Carcinoma
    Sage, E. K.
    Vogel, M. M. E.
    Dewes, S.
    Devecka, M.
    Eiber, M.
    Gschwend, J. E.
    Combs, S. E.
    Schiller, K.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S160 - S161
  • [22] Renal atrophy after stereotactic body radiotherapy for renal cell carcinoma
    Yamamoto, Takaya
    Kadoya, Noriyuki
    Takeda, Ken
    Matsushita, Haruo
    Umezawa, Rei
    Sato, Kiyokazu
    Kubozono, Masaki
    Ito, Kengo
    Ishikawa, Yojiro
    Kozumi, Maiko
    Takahashi, Noriyoshi
    Katagiri, Yu
    Onishi, Hiroshi
    Jingu, Keiichi
    RADIATION ONCOLOGY, 2016, 11
  • [23] Stereotactic body radiotherapy as "first-line treatment" for oligometastatic renal cell cancer
    Guckenberger, Matthias
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (05) : 497 - 499
  • [24] The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma
    Ali, Muhammad
    Mooi, Jennifer
    Lawrentschuk, Nathan
    Mckay, Rana R.
    Hannan, Raquibul
    Lo, Simon S.
    Hall, William A.
    Siva, Shankar
    EUROPEAN UROLOGY, 2022, 82 (06) : 613 - 622
  • [25] Stereotactic Body Radiotherapy for Large Primary Renal Cell Carcinoma
    Kaidar-Person, Orit
    Price, Alex
    Schreiber, Eric
    Zagar, Timothy M.
    Chen, Ronald C.
    CLINICAL GENITOURINARY CANCER, 2017, 15 (05) : E851 - E854
  • [26] Total ablative stereotactic body radiotherapy to primary and oligometastatic renal cell carcinoma in medically inoperable cases: An institutional analysis
    Bisht, Shyam Singh
    Kataria, Tejinder
    Shishak, Sorun
    Gupta, Deepak
    Kaliyaperumal, Venkatesan
    Wadhwa, Jyoti
    Suryavanshi, Manav
    Banerjee, Susovan
    Narang, Kushal
    Goyal, Shina
    Rathi, Deepak
    Mayank, Mayur
    Selvaraj, Rajesh
    Khandelwal, Anubhav
    INDIAN JOURNAL OF UROLOGY, 2023, 39 (04) : 303 - 310
  • [27] Stereotactic body radiotherapy (SBRT)/stereotactic ablative body radiotherapy (SABR) for "radioresistant" renal cell carcinoma (RCC)
    Ishiyama, Hiromichi
    Blanco, Angel I.
    Lo, Simon S.
    Butler, E. Brian
    Teh, Bin S.
    JOURNAL OF RADIATION ONCOLOGY, 2014, 3 (04) : 339 - 346
  • [28] Stereotactic Body Radiotherapy for Oligometastatic Disease
    Hanna, G. G.
    Landau, D.
    CLINICAL ONCOLOGY, 2015, 27 (05) : 290 - 297
  • [29] Stereotactic Body Radiotherapy for Renal Cell Carcinoma: Oncological and Renal Function Outcomes
    Glicksman, R. M.
    Cheung, P.
    Korol, R.
    Niglas, M.
    Nusrat, H.
    Erler, D.
    Vesprini, D.
    Swaminath, A.
    Davidson, M.
    Zhang, L.
    Chu, W.
    CLINICAL ONCOLOGY, 2023, 35 (01) : 20 - 28
  • [30] STEREOTACTIC BODY RADIOTHERAPY FOR RENAL CELL CARCINOMA: ONCOLOGIC AND RENAL FUNCTION OUTCOMES
    Glicksman, Rachel
    Cheung, Patrick
    Korol, Renee
    Niglas, Mark
    Nusrat, Humza
    Erler, Darby
    Vesprini, Danny
    Swaminath, Anand
    Davidson, Melanie
    Zhang, Liying
    Chu, William
    RADIOTHERAPY AND ONCOLOGY, 2022, 174 : S34 - S34
12345